Excimer Light Versus Blue Light in Acne | NCT06725303

Studies
Excimer Light Versus Blue Light in Acne

NCT06725303

Sponsor

Cairo University

Status

Not yet recruiting

Last Update Posted

May 14, 2025Actual

Enrollment

24Estimated

Phase

Not Applicable

Conditions

Acne Vulgaris

Interventions

Excimer

Countries

Not provided

Protocol Section

Identification Module Status Module Sponsor/Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms/Interventions Module Outcomes Module Eligibility Module Contacts/Locations Module References Module IPD Sharing Statement Module

Results Section

Participant Flow Module Baseline Characteristics Module Outcome Measures Module Adverse Events Module More Info Module

Annotation Section

Annotation Module

Document Section

Large Document Module

Derived Section

Miscellaneous Info Module Condition Browse Module Intervention Browse Module

Protocol Section

Identification Module

NCT ID

Results Section

No data available

No data is available for this block.

Annotation Section

No data available

No data is available for this block.

Document Section

No data available

No data is available for this block.

Derived Section

Miscellaneous Info Module

Version Holder

Status Module

Record Verification Date

May 2025

Overall Recruitment Status or Expanded Access Status

Not yet recruiting

Last Known Status

Not provided

Delayed Posting

Not provided

Why Stopped

Not provided

Expanded Access Info

Start Date

Jun 1, 2025Estimated

Primary Completion Date

Jul 1, 2025Estimated

Completion Date

Oct 1, 2025Estimated

First Submitted Date

Dec 8, 2024

First Submission Date that Met QC Criteria

Dec 8, 2024

First Posted Date

Dec 10, 2024Actual

Results Waived

Not provided

Results First Submitted Date

Not provided

Results First Submitted that Met QC Criteria

Not provided

Results First Posted Date

Not provided

Certification/Extension (aka Delayed Results) First Submitted Date

Not provided

Certification/Extension First Submitted that Passed QC Review

Not provided

Certification/Extension First Posted Date

Not provided

Last Update Submitted Date

May 10, 2025

Last Update Posted Date

May 14, 2025Actual

Oversight Module

Has Data Monitoring Committee (DMC)

Not provided

Is FDA Regulated Drug

Is FDA Regulated Device

Is Unapproved Device

Not provided

Pediatric Postmarket Surveillance of a Device Product

Not provided

Product Exported from US

Not provided

FDAAA801 Violation

Not provided

Description Module

Brief Summary

The aim is to assess the efficacy and safety of Excimer Light versus blue light in the treatment of inflammatory acne.

Detailed Description

The use of new light energy in inflammatory acne

Design Module

Study Type

Interventional

Number of References to an Expanded Access Study

Not provided

Expanded Access Types

Not provided

Patient Registry

Not provided

Target Follow-Up Duration

Not provided

Phases

Not Applicable

Interventional Study Design

Allocation

Biospecimen

No data available

No data is available for this block.

Enrollment

24Estimated

Arms/Interventions Module

Arm Groups

Label	Type	Description	Intervention Names
Excimer light	Experimental	Light energy	Device: Excimer
Blue light	Active Comparator	Light energy	Device: Excimer

Interventions

Name	Type	Description	Arm Group Labels	Other Names
Excimer	Device	Light energy	Blue light Excimer light

Outcomes Module

Primary Outcomes

Measure	Description	Time Frame
Number of comedones, papules and pustules	number of lesions	2 months

Secondary Outcomes

Not provided

Other Outcomes

Not provided

Eligibility Module

Eligibility Criteria

Inclusion Criteria:

Patients with mild to moderate inflammatory acne lesions

Exclusion Criteria:

Pregnancy during the first trimester
- Female patients with a medical history of PCO
- Topical and systemic treatment within the last month and systemic retinoids for 6 months
- Patients on systemic steroid treatment or hormonal therapy
- Severe systemic illness or malignancy
- Photosensitivity
- Scarring acne vulgaris

Accepts Healthy Volunteers

Sex

All

Sex/Gender Based

Not provided

Sex/Gender Description

Not provided

Minimum Age

18 Years

Maximum Age

25 Years

Standard Ages

Adult

Study Population

Not provided

Sampling Method

Not provided

Condition Browse Module

MeSH Terms

ID	Term
D000152	Acne Vulgaris

Ancestor Terms

ID	Term
D017486	Acneiform Eruptions
D012871	Skin Diseases
D017437	Skin and Connective Tissue Diseases
D012625	Sebaceous Gland Diseases

Browse Leaves

Not provided

Browse Branches

Not provided

Intervention Browse Module

MeSH Terms

ID	Term
D054018	Lasers, Excimer

Ancestor Terms

ID	Term
D007834	Lasers
D055096	Optical Devices
D004864	Equipment and Supplies
D055618	Radiation Equipment and Supplies

Browse Leaves

Not provided

Browse Branches

Not provided